(2006). A double-blind placebo-controlled evaluation of sublingual immunotherapy with a standardized ragweed extract in patients with seasonal rhinitis. Evidence for a dose-response relationship. Int Arch Allergy Immunol 2003;131:111–8. 60 Allergy, Asthma,
A double-blind, placebo-controlled birch allergen vaccination study: inhibition of CD23-mediated serum-immunoglobulin E–facilitated allergen presentation.
(1994). A double-blind, placebo-controlled trial by sublingual route of immunotherapy with a standardized grass pollen extract. Allergy
A position paper of the Thoracic Society of Australia and New Zealand and the Australasian Society of Clinical Immunology and Allergy. Specific allergen immunotherapy for asthma.
(1994). AAAAI position statement 25. Guidelines to minimize the risk from systemic reactions caused by immunotherapy with allergen extracts.
(1978). Acontrolled trial of immunotherapy in insect hypersensitivity.
Advances in upper airway diseases and allergen immunotherapy.
(2004). Adverse effects and fatalities associated with subcutaneous allergen immunotherapy.
Adverse effects of allergen immunotherapy: assessment and treatment. In:
(1993). Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals.
(2003). Allergen immunotherapy for asthma. Cochrane Database Syst Rev
(2003). Allergen immunotherapy: a practice parameter. Ann Allergy Asthma Immunol
Allergen immunotherapy: practice parameter,
(1998). Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper.
(2004). Allergen immunotherapy: therapeutic vaccines for asthma. In:
Allergens and allergen immunotherapy—practical clinical applications.